2 completed, 1 recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Recruiting 1 |
Follow Single Ventricle Heart Disease: new trials by email Literature Review of Single Ventricle Heart Disease trials Research Report on Single Ventricle Heart Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fontan Udenafil Exercise Longitudinal Assessment Trial - 2 Udenafil, Placebo - Single Ventricle Heart Disease | Phase 3 | Recruiting | Mezzion Pharma Co. Ltd | 436 | 2023-10-30 | 2025-10-28 |
| Evaluation of Fontan-associated Hepatic Stiffness and the Efficacy of Udenafil in Reducing Liver Stiffness Udenafil - Single Ventricle Heart Disease | Phase 3 | Completed | Mezzion Pharma Co. Ltd | 88 | 2018-02-20 | 2025-10-14 |
| Fontan Udenafil Exercise Longitudinal Assessment Trial Udenafil, Placebo - Single Ventricle Heart Disease | Phase 3 | Completed | Mezzion Pharma Co. Ltd | 400 | 2016-07-22 | 2025-06-17 |
udenafil (3)
United States (3) · Canada (2) · South Korea (2)
David J Goldberg, MD (1) · Kurt R Schumacher, MD (1) · Steve Paridon, MD (1) · WG Kim (1)
PMID 29910047, PMID 31736357, PMID 36378780
U01HL068270 (2)